Works matching IS 22872728 AND DT 2025 AND VI 31

Results: 170

Reply to correspondence on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e232, doi. 10.3350/cmh.2025.0203

By:

Chen-Hua Liu;
Yu-Ping Chang

Publication type:

Article

Reply to correspondence 2 on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e228, doi. 10.3350/cmh.2025.0195

By:

Nahee Hwang;
Sungsoon Fang

Publication type:

Article

Reply to correspondence 1 on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e226, doi. 10.3350/cmh.2025.0128

By:

Yoon-su Ha;
Won Kim;
Seung-Jin Kim

Publication type:

Article

Decreasing systemic inflammation after TIPS: Still hope for the liver: Reply to correspondence on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e224, doi. 10.3350/cmh.2025.0149

By:

Semmler, Georg;
Balcar, Lorenz;
Mandorfer, Mattias

Publication type:

Article

Reply to correspondence on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e221, doi. 10.3350/cmh.2025.0226

By:

Jeayeon Park;
Su Jong Yu

Publication type:

Article

Reply to correspondence on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e218, doi. 10.3350/cmh.2025.0070

By:

Jing Zeng;
Jian-Gao Fan

Publication type:

Article

Reply to correspondence on “Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e215, doi. 10.3350/cmh.2025.0035

By:

Hyuk Soo Eun

Publication type:

Article

Correspondence to letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e212, doi. 10.3350/cmh.2025.0100

By:

Soon Kyu Lee;
Jong Young Choi

Publication type:

Article

Correspondence to letter to the editor 2 on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e210, doi. 10.3350/cmh.2024.1175

By:

Seogsong Jeong;
Won Kim;
Sang Min Park

Publication type:

Article

Correspondence to letter to the editor 1 on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e208, doi. 10.3350/cmh.2024.1171

By:

Seogsong Jeong;
Won Kim;
Sang Min Park

Publication type:

Article

Correspondence to editorial on “Exploring methylation signatures for high de novo recurrence risk in hepatocellular carcinoma”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e206, doi. 10.3350/cmh.2025.0164

By:

Kwang-Woong Lee;
Young-Joon Kim

Publication type:

Article

Correspondence to editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e203, doi. 10.3350/cmh.2025.0179

By:

Tom Ryu;
Young Chang;
Seung Up Kim;
Jae Young Jang

Publication type:

Article

Correspondence to editorial on “Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000-2021”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e200, doi. 10.3350/cmh.2025.0166

By:

Danpanichkul, Pojsakorn;
Diaz, Luis Antonio;
Suparan, Kanokphong;
Wijarnpreecha, Karn;
Arab, Juan Pablo

Publication type:

Article

Correspondence to editorial on “Targeting TM4SF1 promotes tumor senescence enhancing CD8+ T cell cytotoxic function in hepatocellular carcinoma”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e197, doi. 10.3350/cmh.2025.0085

By:

Weifeng Zeng;
Furong Liu;
Yachong Liu;
Zhanguo Zhang

Publication type:

Article

Correspondence to editorial on “Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e194, doi. 10.3350/cmh.2025.0181

By:

Haolong Li;
Song Liu;
Xu Wang;
Li Wang;
Tengda Xu;
Yongzhe Li

Publication type:

Article

Correspondence to editorial on “Integrated molecular characterization of sarcomatoid hepatocellular carcinoma”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e192, doi. 10.3350/cmh.2025.0183

By:

Rong-Qi Sun;
Shao-Lai Zhou

Publication type:

Article

GOLM1 and bile acid synthesis: Correspondence to editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e189, doi. 10.3350/cmh.2025.0120

By:

Yi-Tong Li;
Wei-Qing Shao;
Zhen-Mei Chen;
Jing Lin;
Jin-Hong Chen

Publication type:

Article

Correspondence to editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e186, doi. 10.3350/cmh.2025.0079

By:

Yi-Tong Li;
Wei-Qing Shao;
Zhen-Mei Chen;
Jing Lin;
Jin-Hong Chen

Publication type:

Article

The burden of steatotic liver disease before and during the COVID-19 pandemic: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e183, doi. 10.3350/cmh.2025.0152

By:

Kim, Donghee;
Danpanichkul, Pojsakorn;
Wijarnpreecha, Karn;
Cholankeril, George;
Loomba, Rohit;
Ahmed, Aijaz

Publication type:

Article

Addressing the burden of steatotic liver disease: The role of transient elastography: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e180, doi. 10.3350/cmh.2025.0125

By:

Kim, Donghee;
Danpanichkul, Pojsakorn;
Wijarnpreecha, Karn;
Cholankeril, George;
Loomba, Rohit;
Ahmed, Aijaz

Publication type:

Article

TIPS insertion and systemic inflammation: Is it ever too late to lower portal pressure? Correspondence to editorial on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e176, doi. 10.3350/cmh.2025.0135

By:

Tiede, Anja;
Maasoumy, Benjamin

Publication type:

Article

Correspondence to editorial on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e173, doi. 10.3350/cmh.2025.0001

By:

Rouillard, Nicholas A.;
Henry, Linda;
Nguyen, Mindie H.

Publication type:

Article

Expanding treatment eligibility for chronic hepatitis B: Balancing benefits, limitations, and healthcare access: Correspondence to editorial on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e169, doi. 10.3350/cmh.2024.1138

By:

Yao-Chun Hsu;
Chi-Yi Chen;
Jaw-Town Lin

Publication type:

Article

Correspondence to editorial on “Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e166, doi. 10.3350/cmh.2024.1185

By:

Yang Liu;
Fan Peng;
Siyuan Wang;
Jinliang Xing

Publication type:

Article

HCV self-testing: Bridging screening gaps and ensuring cost-effectiveness for both high-risk and universal populations: Correspondence to editorial on “Selftesting strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of disease burden and cost-effectiveness”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e163, doi. 10.3350/cmh.2024.1057

By:

Gyeongseon Shin;
Beom Kyung Kim;
SeungJin Bae;
Hankil Lee;
Sang Hoon Ahn

Publication type:

Article

Correspondence to editorial on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e161, doi. 10.3350/cmh.2025.0121

By:

Soon Kyu Lee;
Jong Young Choi

Publication type:

Article

Correspondence to editorial on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e158, doi. 10.3350/cmh.2024.0989

By:

Woo Hyun Paik;
Do Hyun Park

Publication type:

Article

Correspondence to editorial on “Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e155, doi. 10.3350/cmh.2024.0723

By:

Chuan Liu;
Ling Yang;
Hong You;
Gao-Jun Teng;
Xiaolong Qi

Publication type:

Article

Age serves as the silent architect of FIB-4’s precision in unveiling advanced hepatic fibrosis in MASLD with T2DM: Correspondence to letter to the editor on “Diagnostic accuracy of the fibrosis-4 index for advanced liver fibrosis in nonalcoholic fatty liver disease with type 2 diabetes: a systematic review and meta-analysis”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e152, doi. 10.3350/cmh.2024.1160

By:

Ji Won Han;
Dae Won Jun

Publication type:

Article

Correspondence to letter to the editor on “Contemporary awareness of viral hepatitis between 2012 and 2022 among Korean adults”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e149, doi. 10.3350/cmh.2024.0944

By:

Chang Hun Lee;
In Hee Kim;
Sook-Hyang Jeong

Publication type:

Article

Prevalence of steatotic liver disease and associated fibrosis in the general population: An epidemiological survey: Letter to the editor on “Epidemiology of metabolic dysfunction-associated steatotic liver disease”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e145, doi. 10.3350/cmh.2024.0921

By:

Lin Guan;
Xinhe Zhang;
Shanghao Liu;
Xiaolong Qi;
Yiling Li

Publication type:

Article

Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e143, doi. 10.3350/cmh.2025.0140

By:

Wei Wang;
Yating Xie;
Ailei Xu

Publication type:

Article

Treatment response to nucleos(t)ide analogs in chronic hepatitis B with mildly elevated alanine aminotransferase: Letter to the editor on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e140, doi. 10.3350/cmh.2024.0960

By:

Jian Wang;
Fei Cao;
Chuanwu Zhu;
Chao Wu;
Rui Huang

Publication type:

Article

Tacrolimus levels and variability in CKD and ESRD risk post-liver transplant: Letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e137, doi. 10.3350/cmh.2024.1159

By:

Rui Shi;
Minghua Wang

Publication type:

Article

Global inequality in the burden of hepatitis B from 1990 to 2021: Findings from the global burden of disease study 2021: Letter to the editor on “Comprehensive approach to controlling chronic hepatitis B in China”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e134, doi. 10.3350/cmh.2024.1085

By:

Chunlong Liu;
Jiangtao Yu

Publication type:

Article

MAFLD or MASLD: Which better represents the prognosis of the steatotic liver population: Letter to the editor on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e128, doi. 10.3350/cmh.2024.1008

By:

Ying Wang;
Shengfeng Wang;
Xiude Fan;
Jiajun Zhao;
Yongfeng Song

Publication type:

Article

Letter to the editor on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. e125, doi. 10.3350/cmh.2024.1087

By:

Hai Xu;
Yong Zhou;
Huikun Wu

Publication type:

Article

Erratum to ‘Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial’ [Clin Mol Hepatol 2024;30:807-823].

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. 669, doi. 10.3350/cmh.2024.0333e

By:

Sun Young Yim;
Sung Hwan Lee;
Seung-Woo Baek;
Sohn, Bohwa;
Yun Seong Jeong;
Sang-Hee Kang;
Kena Park;
Park, Hyewon;
Lee, Sunyoung S.;
Kaseb, Ahmed O.;
Young Nyun Park;
Sun-Hee Leem;
Curran, Michael A.;
Ji Hoon Kim;
Ju-Seog Lee

Publication type:

Article

Modulation of lymphatic vessels in management of liver disease and complications.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. 665, doi. 10.3350/cmh.2024.0793

By:

Sharma, Aarti;
Juneja, Pinky;
Sarin, Shiv K.;
Kaur, Savneet

Publication type:

Article

Screening of patients at high risk of de novo recurrence in HCC: Editorial on “Exploring methylation signatures for high de novo recurrence risk in hepatocellular carcinoma”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. 662, doi. 10.3350/cmh.2025.0106

By:

Ping Huang;
Shiqiao Luo;
Rui Liao

Publication type:

Article

Metabolic dysfunction in patients following DAAinduced viral cure for HCV infection: A non-negligible risk to liver-related health: Editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. 658, doi. 10.3350/cmh.2025.0155

By:

Chen-Hua Liu;
Yu-Ping Chang

Publication type:

Article

Burden of alcohol use disorder, alcohol-related liver disease, and alcohol-related liver cancer: Editorial on “Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000–2021.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. 654, doi. 10.3350/cmh.2025.0133

By:

Youxin Wang;
Noriko Oza;
Leo, Jazleen;
Choudhury, Ashok;
Huang, Daniel Q.

Publication type:

Article

Tetraspan(in)-mediated immune regulation in hepatocellular carcinoma: Editorial on “Targeting TM4SF1 promotes tumor senescence enhancing CD8<sup>+</sup> T cell cytotoxic function in hepatocellular carcinoma”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. 650, doi. 10.3350/cmh.2025.0109

By:

Seo Hee Jin;
Dong Joo Kim;
Jung Weon Lee

Publication type:

Article

TM4SF1 - A new immune target for treatment of hepatocellular carcinoma: Editorial on “Targeting TM4SF1 promotes tumor senescence enhancing CD8+ T cell cytotoxic function in hepatocellular carcinoma”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. 646, doi. 10.3350/cmh.2025.0102

By:

Chen Rui Yuan;
Terence Kin Wah Lee

Publication type:

Article

Targeting TM4SF1 to overcome immunotherapy resistance in hepatocellular carcinoma: Editorial on “Targeting TM4SF1 promotes tumor senescence enhancing CD8+ T cell cytotoxic function in hepatocellular carcinoma”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. 642, doi. 10.3350/cmh.2025.0031

By:

Chew, Valerie

Publication type:

Article

Is AMA M2 a useful serologic test for screening highrisk patients for PBC?: Editorial on “Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. 640, doi. 10.3350/cmh.2025.0117

By:

Nae-Yun Heo

Publication type:

Article

Genetic insights into sarcomatoid hepatocellular carcinoma: Critical role of ARID2 in pathogenesis and immune feature: Editorial on “Integrated molecular characterization of sarcomatoid hepatocellular carcinoma”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. 635, doi. 10.3350/cmh.2025.0071

By:

Naoshi Nishida

Publication type:

Article

Bridging the gap: The GOLM1-OPN-ABCG5 axis in MASH and gallstone disease: Editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. 631, doi. 10.3350/cmh.2025.0066

By:

Nahee Hwang;
Sungsoon Fang

Publication type:

Article

Unraveling the role of GOLM1-OPN-ABCG5 axis in MASH: Editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. 628, doi. 10.3350/cmh.2025.0036

By:

Yoon-su Ha;
Won Kim;
Seung-Jin Kim

Publication type:

Article

Revealing the importance of a multidisciplinary approach to reducing the global burden of SLD through the COVID-19 pandemic: Editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023”.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 2, p. 625, doi. 10.3350/cmh.2025.0019

By:

Jeayeon Park;
Su Jong Yu

Publication type:

Article